Menu
1-702-720-6310 info@microcapspecualtors.com

Celgene: A ‘Fuggedaboutit’ Core Biotech Holding – Seeking Alpha

Celgene: A ‘Fuggedaboutit’ Core Biotech Holding
Seeking Alpha
Few large-cap biotech concerns have a clearer earnings and revenue growth trajectory over the next 3-5 years than Celgene. It has a blockbuster blood cancer drug, several other solid compounds in its product portfolio, a deep pipeline, and dozens of …

Search